The o2h group seeds new ideas in life science and technology. The purpose is to contribute to novel science to address unmet therapeutic needs through funding, incubation, and collaborative execution. o2h operates in the pre-clinical phase between idea generation and the identification of lead/development candidates, drawing on core strengths across chemistry, biology and technology. The group also remains committed to reinvesting resources, energy, gratitude and support into the heritage ecosystems from which it emerged, as well as the wider global ecosystems in which it operates.

At o2h co-discovery, we have a proprietary operating system for fast tracking new ideas to a development candidate. The core is an insight driven integrated multi-modality drug discovery platform that combines novel capability with strategic partners embedded in AI enabled backbone to create a unique workflow.

The o2h group is co-located in Cambridge, UK and in Ahmedabad, India and has six verticals covering: ventures, discovery, technology, incubate, community and therapeutics.

Press Release – Curza and o2h discovery announce a multi-FTE chemistry collaboration against gram negative